Duke Cancer Network — Clayton, North Carolina

Duke Cancer Network is a clinical research site located in Clayton, North Carolina, United States 27520.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Cancer Network has participated in 1 clinical trials.

Therapeutic areas: Warm Antibody Autoimmune Hemolytic Anemia.

Sponsors: Rigel Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Network?

Duke Cancer Network has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Network conducted?

Duke Cancer Network has 1 clinical trials on record. Their work covers Warm Antibody Autoimmune Hemolytic Anemia.

Is Duke Cancer Network accredited by Crixeo Health?

Duke Cancer Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.